These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19125945)

  • 1. Clinical epidemiology of fulminant hepatitis in Japan.
    Takikawa Y; Suzuki K
    Hepatol Res; 2008 Nov; 38 Suppl 1():S14-8. PubMed ID: 19125945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing etiologies and outcomes of acute liver failure: A perspective from Japan.
    Oketani M; Ido A; Tsubouchi H
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():65-71. PubMed ID: 21199516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.
    Sato S; Suzuki K; Takikawa Y; Endo R; Omata M;
    Hepatol Res; 2004 Nov; 30(3):155-161. PubMed ID: 15588781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatitis and late onset hepatic failure in Japan.
    Fujiwara K; Mochida S; Matsui A; Nakayama N; Nagoshi S; Toda G;
    Hepatol Res; 2008 Jul; 38(7):646-57. PubMed ID: 18328067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009.
    Oketani M; Ido A; Nakayama N; Takikawa Y; Naiki T; Yamagishi Y; Ichida T; Mochida S; Onishi S; Tsubouchi H;
    Hepatol Res; 2013 Feb; 43(2):97-105. PubMed ID: 23409848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center.
    Fujiwara K; Yasui S; Kondo T; Nakamura M; Arai M; Kanda T; Yokosuka O; Ohtsuka M; Abe R; Kato N
    Hepatol Res; 2023 Apr; 53(4):357-369. PubMed ID: 36541110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of fulminant hepatitis with highly reliable artificial liver support and administration of interferon].
    Iwamura Y; Yoshiba M; Sugata F
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jan; 87(1):109-18. PubMed ID: 1691801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present status of fulminant hepatitis in Japan (1989-1991).
    Muto Y
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():120-7. PubMed ID: 8486223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication criteria for liver transplantation for acute liver failure in Japan.
    Mochida S
    Hepatol Res; 2008 Nov; 38 Suppl 1():S52-5. PubMed ID: 19125953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.
    Bismuth H; Azoulay D; Samuel D; Reynes M; Grimon G; Majno P; Castaing D
    Ann Surg; 1996 Dec; 224(6):712-24; discussion 724-6. PubMed ID: 8968226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Fulminant Hepatitis B.
    Ichai P; Samuel D
    Curr Infect Dis Rep; 2019 Jun; 21(7):25. PubMed ID: 31165271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune fulminant liver failure in adults: Experience in a Japanese center.
    Fujiwara K; Yasui S; Tawada A; Okitsu K; Yonemitsu Y; Chiba T; Arai M; Kanda T; Imazeki F; Nakano M; Oda S; Yokosuka O
    Hepatol Res; 2011 Feb; 41(2):133-41. PubMed ID: 21269383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis.
    Fujiwara K; Abe R; Yasui S; Yokosuka O; Kato N; Oda S
    Hepatol Res; 2019 Feb; 49(2):224-231. PubMed ID: 30277289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or co-factor?
    Jain A; Kar P; Madan K; Das UP; Budhiraja S; Gopalkrishna V; Sharma JK; Das BC
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1231-7. PubMed ID: 10563532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.
    Yoshiba M; Sekiyama K; Iwamura Y; Sugata F
    Dig Dis Sci; 1993 Mar; 38(3):469-76. PubMed ID: 8444078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis.
    Takahashi Y; Shimizu M
    J Gastroenterol Hepatol; 1991; 6(2):159-64. PubMed ID: 1912424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parameter in fulminant hepatitis].
    Moritoh T; Kuroda M; Takagi T; Ohkuma Y; Saitoh K
    Rinsho Byori; 1991 Jan; 39(1):34-40. PubMed ID: 2008037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
    Yoshiba M; Inoue K; Sekiyama K; Koh I
    Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.